Cargando…
Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline
Despite the uncertainty of the pathogenesis of systemic lupus erythematosus, novel small molecules targeting specific intracellular mechanisms of immune cells are being developed to reverse the pathophysiological processes. These targeted molecules have the advantages of convenient administration, l...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042116/ https://www.ncbi.nlm.nih.gov/pubmed/36972009 http://dx.doi.org/10.1007/s40265-023-01856-x |